Please assess the completion status of the following clinical trial:

Trial Title: Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed adenocarcinoma of the prostate (Biopsy within one year of enrollment)~* Signed Study-Specific Consent~* PSA within 60 days of registration~* Baseline American Urological Association (AUA)/ International Prognostic Scoring System (IPSS) score of \< 20~* Candidate for screening colonoscopy~* Pretreatment Colonoscopy/lower endoscopy done~Exclusion Criteria:~* Prior pelvic radiotherapy~* Prior radical prostate surgery~* Recent (within 5 years) or concurrent cancers other than non-melanoma skin cancer~* Implanted hardware adjacent to the prostate that would prohibit appropriate treatment planning and/or treatment delivery~* Inflammatory bowel disease

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CyberKnife Radiosurgery, Colonoscopy (Type: OTHER): CyberKnife radiosurgery for prostate cancer; bowel toxicity will be evaluated at 2 years by colonoscopy (lower endoscopy).

Based on this trial design, predict the completion outcome and termination type (if applicable).